Erlotinib as second-line treatment in patients with advanced non-small-cell lung cancer and asymptomatic brain metastases: a phase II study (CTONG-0803)
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Erlotinib as second-line treatment in patients with advanced non-small-cell lung cancer and asymptomatic brain metastases: a phase II study (CTONG-0803)
Authors
Keywords
-
Journal
ANNALS OF ONCOLOGY
Volume 24, Issue 4, Pages 993-999
Publisher
Oxford University Press (OUP)
Online
2012-11-06
DOI
10.1093/annonc/mds529
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy and safety of maintenance erlotinib in Asian patients with advanced non-small-cell lung cancer: A subanalysis of the phase III, randomized SATURN study
- (2012) Yi-Long Wu et al. LUNG CANCER
- Biomarkers of clinical benefit for anti-epidermal growth factor receptor agents in patients with non-small-cell lung cancer
- (2011) A G Pallis et al. BRITISH JOURNAL OF CANCER
- Efficacy of increased-dose erlotinib for central nervous system metastases in non-small cell lung cancer patients with epidermal growth factor receptor mutation
- (2011) Yosuke Togashi et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Medical Management of Patients With Brain Tumors
- (2011) Amy A. Pruitt Current Treatment Options in Neurology
- Erlotinib Accumulation in Brain Metastases from Non-small Cell Lung Cancer: Visualization by Positron Emission Tomography in a Patient Harboring a Mutation in the Epidermal Growth Factor Receptor
- (2011) Britta Weber et al. Journal of Thoracic Oncology
- Randomized phase II study of gefitinib versus erlotinib in patients with advanced non-small cell lung cancer who failed previous chemotherapy
- (2011) Seung Tae Kim et al. LUNG CANCER
- "Pulsatile" high-dose weekly erlotinib for CNS metastases from EGFR mutant non-small cell lung cancer
- (2011) C. Grommes et al. NEURO-ONCOLOGY
- Multimodality treatment of brain metastases: an institutional survival analysis of 275 patients
- (2011) Ameer L Elaimy et al. World Journal of Surgical Oncology
- Treatment of Brain Metastases: Chemotherapy
- (2011) Sean A. Grimm Current Oncology Reports
- Multimodality management of non-small cell lung cancer patients with brain metastases
- (2010) Serena Ricciardi et al. CURRENT OPINION IN ONCOLOGY
- Brain metastases from lung cancer responding to erlotinib: the importance of EGFR mutation
- (2010) R. Porta et al. EUROPEAN RESPIRATORY JOURNAL
- High dose weekly erlotinib achieves therapeutic concentrations in CSF and is effective in leptomeningeal metastases from epidermal growth factor receptor mutant lung cancer
- (2010) Jennifer L. Clarke et al. JOURNAL OF NEURO-ONCOLOGY
- Risk of Intracranial Hemorrhage and Cerebrovascular Accidents in Non-small Cell Lung Cancer Brain Metastasis Patients
- (2010) Geetika Srivastava et al. Journal of Thoracic Oncology
- Erlotinib as maintenance treatment in advanced non-small-cell lung cancer: a multicentre, randomised, placebo-controlled phase 3 study
- (2010) Federico Cappuzzo et al. LANCET ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started